Increased Prevalence of Cardiovascular and Lifestyle Diseases Driving the Cardiovascular Devices Market in Emerging Countries

Friday 21 October 2011, Amsterdam

Increased Prevalence of Cardiovascular and Lifestyle Diseases Driving the Cardiovascular Devices Market in Emerging Countries

Lifestyle changes have led to a growing incidence of lifestyle diseases in emerging countries. It has been recently projected that the incidence of cardiovascular disease will increase by 73% by 2030 in China.

The prevalence of risk factors such as diabetes and obesity is increasing in China, India and Brazil. Dietary changes, undue stress and changes in lifestyle are leading to more cases of diabetes, obesity, hyperlipidemia, smoking and hypertension, which are all major risk factors for developing cardiovascular diseases. India has the highest number of disability adjusted life years (DALYS) lost due to CHD of the emerging economies in the world. The number of DALYS lost in India stands at 20 days per 1,000 people, closely followed by Brazil. DALYS combines the years of potential life lost due to premature death with the years of productive life lost due to disability.

The International Diabetes Federation (IDF) estimates that the number of patients with diabetes in India has more than doubled from 19 million in 1995 to 50.7 million in 2010. It is projected to increase to 69.9 million by 2025. Currently, up to 11% of India’s urban population and 3% of its rural population over the age of 15 have diabetes.

Developing countries are also witnessing the fastest growth of obesity. In these countries, the prevalence of obesity has more than tripled. Cardiovascular disease prevalence and the rising incidence of lifestyle disorders are the main factors for the increase in the population pool suffering with cardiovascular diseases, which is a major driver for the cardiovascular devices market in the emerging countries.


China Leads the Cardiovascular Device Market Among the Emerging Countries

China had the largest cardiovascular devices market in 2010 among the emerging countries, with a total market value of about $1 billion. This value is estimated to reach $1.3 billion in 2017. The cardiovascular devices market in India was the second largest cardiovascular devices market among the emerging countries and was valued at $476m in 2010. It is expected to reach $589m in 2017. The cardiovascular devices market in Brazil in 2010 was worth $490m and is estimated to reach $759.2m in 2017. The rise in cardiovascular disease incidence, the increased spending power of the population, the higher penetration of health care insurance products and the increased focus of multinational cardiovascular companies have been the major drivers of the cardiovascular devices market in emerging countries.


India is Growing as an Important Destination for Cardiac Medical Tourism

India is gaining importance as a destination for medical tourism and in particular for the treatment of cardiovascular diseases and surgeries. Complex cardiovascular procedures such as cardiac bypass surgery, cardiac valve repair and replacement and minimally invasive cardiac stenting and angioplasty are procedures that are quite easily taken up in various urban hospitals in India at a lower cost than in the West and even other Asian countries.

The low cost of treatment, scale and range of treatment options provided in India, the availability of world class infrastructure, proficient English speaking doctors and paramedical staff and the adoption of medical technologies are some of the factors that are facilitating India’s growth as a center for medical tourism.


Medtronic, Boston Scientific and Terumo Lead the Cardiovascular Devices Market in the Emerging Countries

In China, Boston Scientific was the market leader with a share of 11% in 2010, followed by Chinese major Lepu Medical Technology and Medtronic, with a 10% market share each. Another Chinese major company Microport had a share of 9%. Other companies with a significant presence are Terumo Corporation (7%), Abbott Laboratories (6%), and Biosensors International Group (5%).

In India, Medtronic was the market leader with a share of 14% in 2010, followed by Terumo Corporation and Boston Scientific with a 10% market share each. The other companies with significant presence were Abbott Laboratories (9%), St. Jude Medical (6%) and Cordis Corporation (6%).

In Brazil, Medtronic was the market leader with a share of 19% in 2010, followed by Boston Scientific with 11% and St. Jude Medical with a 9% market share. The other companies with a significant presence were Cordis Corporation (8%) and Edwards Lifesciences, Abbott Laboratories and Sorin (4%).



About this new market study:
The report provides market landscape, competitive landscape and market trends information on cardiac rhythm management devices, external defibrillator market, Interventional cardiology, peripheral vascular devices, cardiovascular prosthetic devices, cardiac assist devices, cardiovascular surgery, electrophysiology, cardiovascular monitoring and diagnostic devices in the emerging countries. The report provides comprehensive information on the key trends affecting these categories, and key analytical content on the market dynamics. The report also reviews the competitive landscape and the profiles of companies operating in these geographies.